Penumbra is a global healthcare company headquartered in Alameda, California, founded in 2004. With over 4,500 team members operating across more than 100 markets worldwide, the company designs, develops, and manufactures medical devices targeting some of the most challenging conditions in neurovascular and vascular medicine.
The company's portfolio spans thrombectomy systems for stroke intervention, embolization technologies, neurovascular devices, and the Lightning Flash technology for pulmonary embolism treatment. Its REAL immersive healthcare platform extends the focus into rehabilitation. Each product line addresses conditions where unmet clinical need remains substantial - stroke, pulmonary embolism, and complex vascular pathologies.
Penumbra's technical work spans the full lifecycle of medical device innovation: design, development, and manufacturing under one roof. The company describes its culture as one where everyone's ideas matter and where teams are constantly learning and growing together. For engineers and scientists drawn to building devices that operate at the frontier of interventional medicine, the breadth and ambition of Penumbra's pipeline is notable.
